Skip to main content
Livermore
Livermore
ZHEN

IFP Advisors, Inc

SEC CIK
0001641866
Latest filing
Jul 20, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by IFP Advisors, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
3,939
Value
$308.3K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of HALO by IFP Advisors, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,939$308.3K<0.1%+324+9.0%AddedHolders
Q1 20263,615$233.6K<0.1%−31−0.9%ReducedHolders
Q4 20253,646$245.4K<0.1%−1,560−30.0%ReducedHolders
Q3 20255,206$381.8K<0.1%+785+17.8%AddedHolders
Q2 20254,421$232.9K<0.1%+2,318+110.2%AddedHolders
Q1 20252,103$134.2K<0.1%+2,018+2,374.1%AddedHolders
Q4 202485$4.06K<0.1%+85NewHolders
Q3 20240$00.0%−2,027−100.0%Sold outHolders
Q2 20242,027$106.1K<0.1%+2,000+7,407.4%AddedHolders
Q1 202427$1.10K<0.1%+27NewHolders
Q3 20230$00.0%−23−100.0%Sold outHolders
Q2 202323$428<0.1%−502−95.6%ReducedHolders
Q1 2023525$9.76K<0.1%+21+4.2%AddedHolders
Q4 2022504$13.0K<0.1%−1,213−70.6%ReducedHolders
Q3 20221,717$38.0K<0.1%+803+87.9%AddedHolders
Q2 2022914$18.0K<0.1%−28−3.0%ReducedHolders
Q1 2022942$19.0K<0.1%+914+3,264.3%AddedHolders
Q4 202128$1.00K<0.1%−1,837−98.5%ReducedHolders
Q3 20211,865$78.0K<0.1%−57−3.0%ReducedHolders
Q2 20211,922$88.0K<0.1%−1,020−34.7%ReducedHolders
Q1 20212,942$123.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.